[Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study].
Mundschenk
J
J
Kopf
D
D
Lehnert
H
H
D019797:3-Iodobenzylguanidine; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007205:Indium Radioisotopes; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D007457:Iodine Radioisotopes; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010919:Placebos; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D007205:Indium Radioisotopes; D016898:Interferon-alpha; D007457:Iodine Radioisotopes; D010919:Placebos; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; D014750:Vincristine; D003606:Dacarbazine; D003520:Cyclophosphamide; D015282:Octreotide
Therapie des malignen Phäochromozytoms. Aufruf zur Teilnahme an einer randomisierten multizentrischen Studie.